US2167480A
(en)
|
1927-11-02 |
1939-07-25 |
Rca Corp |
Signaling
|
US4703004A
(en)
|
1984-01-24 |
1987-10-27 |
Immunex Corporation |
Synthesis of protein with an identification peptide
|
JPS6440808A
(en)
|
1987-08-05 |
1989-02-13 |
Canon Kk |
Zoom lens
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
US6183745B1
(en)
|
1990-12-12 |
2001-02-06 |
The University Of Queensland |
Subunit papilloma virus vaccine and peptides for use therein
|
CA2115364A1
(en)
|
1991-08-16 |
1993-03-04 |
Philip L. Felgner |
Composition and method for treating cystic fibrosis
|
US6419931B1
(en)
*
|
1991-08-26 |
2002-07-16 |
Epimmune Inc. |
Compositions and methods for eliciting CTL immunity
|
CZ42794A3
(en)
|
1991-08-26 |
1994-11-16 |
Cytel Corp |
Hla-re-stringed ctl epitopes of hepatitis b virus
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
IL105554A
(en)
|
1992-05-05 |
1999-08-17 |
Univ Leiden |
Peptides of human papillomavirus for use in preparations elicit a human T cell response
|
IL105914A0
(en)
|
1992-06-04 |
1993-10-20 |
Univ California |
Methods and compositions for in vivo gene therapy
|
US7105574B1
(en)
|
1999-03-26 |
2006-09-12 |
Vical Incorporated |
Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
US9266930B1
(en)
|
1993-03-05 |
2016-02-23 |
Epimmune Inc. |
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
|
EP0721341A4
(en)
|
1993-08-06 |
1998-04-22 |
Cytel Corp |
CLONING AND DESCRIPTION OF FULL MAGE-1 GENE CHARACTERISTICS
|
AUPM500494A0
(en)
|
1994-04-12 |
1994-05-05 |
Minister For Agriculture & Rural Affairs For The State Of New South Wales, The |
Composition for use in increasing mucosal immunity
|
FR2726764B1
(fr)
|
1994-11-14 |
1997-01-31 |
Pasteur Merieux Serums Vacc |
Adjuvant pour composition vaccinale
|
US6008202A
(en)
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
FR2732895B1
(fr)
|
1995-04-11 |
1997-05-16 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
|
EP0840622A4
(en)
|
1995-07-21 |
2003-01-02 |
Aventis Pharma Inc |
ADENO-ASSOCIATED VIRUS LIPOSOMES AND THEIR USE FOR THE TRANSFECTION OF DENDRITIC CELLS FOR THE STIMULATION OF SPECIFIC IMMUNITY
|
US6610321B2
(en)
|
1996-07-03 |
2003-08-26 |
University Of Pittsburgh |
Emulsion formulations for hydrophilic active agents
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
US7001614B2
(en)
|
1996-08-19 |
2006-02-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
US20030229040A1
(en)
|
1997-03-21 |
2003-12-11 |
Georgetown University |
Cationic liposomal delivery system and therapeutic use thereof
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
WO2000045849A2
(en)
|
1999-02-05 |
2000-08-10 |
Genzyme Corporation |
Use of cationic lipids to generate anti-tumor immunity
|
EP1574210B1
(en)
|
1999-02-26 |
2016-04-06 |
Novartis Vaccines and Diagnostics, Inc. |
Microemulsions with adsorbed macromolecules
|
ATE272410T1
(de)
|
1999-03-26 |
2004-08-15 |
Vical Inc |
Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
|
US6852334B1
(en)
|
1999-04-20 |
2005-02-08 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
JP5117648B2
(ja)
|
1999-04-20 |
2013-01-16 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
カチオン性peg脂質および使用方法。
|
US6649170B1
(en)
|
1999-05-12 |
2003-11-18 |
Statens Serum Institut |
Adjuvant combinations for immunization composition and vaccines
|
FR2794370B1
(fr)
|
1999-06-03 |
2003-10-17 |
Biovector Therapeutics |
Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
|
BR0011732B1
(pt)
|
1999-06-10 |
2014-02-04 |
|
Vacinas de dna para animais de companhia e de esporte
|
CA2309313A1
(en)
|
1999-08-05 |
2001-02-05 |
Board Of Trustees Of The University Of Arkansas |
Stimulation of the immune response by human dendritic cell manipulation
|
PT1214097E
(pt)
|
1999-09-16 |
2009-10-19 |
Eisai Inc |
Ácidos nucleicos que codificam polipéptidos de poliepitopos
|
US20030008813A1
(en)
|
1999-12-17 |
2003-01-09 |
Felgner Philip L. |
Intracellular protein delivery compositions and methods of use
|
US20010026937A1
(en)
|
2000-01-11 |
2001-10-04 |
Juha Punnonen |
Monocyte-derived dendritic cell subsets
|
WO2001057068A1
(en)
*
|
2000-02-01 |
2001-08-09 |
The Austin Research Institute |
Mucin-1 derived antigens and their use in immunotherapy
|
EP1355670A2
(en)
|
2000-04-20 |
2003-10-29 |
University of British Columbia |
Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane destabilisers
|
ATE398175T1
(de)
|
2000-12-08 |
2008-07-15 |
Coley Pharmaceuticals Gmbh |
Cpg-artige nukleinsäuren und verfahren zu ihrer verwendung
|
WO2002060412A2
(en)
|
2001-02-01 |
2002-08-08 |
Board Of Regents |
Stabilised polymeric aerosols for pulmonary gene delivery
|
US7189513B2
(en)
|
2001-03-23 |
2007-03-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Human papilloma virus immunoreactive peptides
|
FR2824326B1
(fr)
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
US7514098B2
(en)
|
2001-05-30 |
2009-04-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Use of targeted cross-linked nanoparticles for in vivo gene delivery
|
CA2489019A1
(en)
*
|
2001-06-15 |
2002-12-27 |
Nordic Vaccine Technology A/S |
Therapeutical vaccination
|
CN1320923C
(zh)
|
2001-06-29 |
2007-06-13 |
中外制药株式会社 |
含有基于癌抑制基因wt1的产物的癌抗原和阳离子脂质体的癌疫苗
|
WO2003003985A2
(en)
*
|
2001-07-06 |
2003-01-16 |
Sloan-Kettering Institute For Cancer Research |
Polyvalent conjugate vaccine for cancer
|
GB0118517D0
(en)
|
2001-07-30 |
2001-09-19 |
Mitsubishi Tokyo Pharm Inc |
Compound
|
DE60238864D1
(de)
|
2001-11-07 |
2011-02-17 |
Mankind Corp |
Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption
|
US7598421B2
(en)
|
2002-05-08 |
2009-10-06 |
Ucl Biomedica Plc |
Materials for the delivery of biologically-active material to cells
|
ES2279127T3
(es)
|
2002-07-05 |
2007-08-16 |
Lipoxen Technologies Limited |
Procedimiento para aumentar una respuesta inmunitaria de vacunacion de acido nucleico.
|
EP2314630A1
(en)
|
2002-08-12 |
2011-04-27 |
The Council Of The Queensland Institute Of Medical Research |
Method of producing immunogenic lipopeptides comprising T-helper and Cytotoxic T Lymphocyte (CTL) epitopes
|
US20050031587A1
(en)
|
2002-10-04 |
2005-02-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Immune response induction method
|
WO2004037175A2
(en)
|
2002-10-21 |
2004-05-06 |
Mgi Pharma Biologics, Inc. |
Compositions and methods for treating human papillomavirus-mediated disease
|
SE0301109D0
(sv)
|
2003-04-14 |
2003-04-14 |
Mallen Huang |
Nucleotide vaccine composition
|
KR20060015265A
(ko)
|
2003-05-30 |
2006-02-16 |
알자 코포레이션 |
제제의 폐 투여 방법
|
US7541035B2
(en)
|
2003-06-05 |
2009-06-02 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Immunogenic peptides for the treatment of prostate and breast cancer
|
WO2004110496A1
(en)
|
2003-06-18 |
2004-12-23 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Sphingoid polyalkylamine conjugates for vaccination
|
US7906122B2
(en)
|
2003-06-18 |
2011-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jersusalem |
Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
US20060182793A1
(en)
|
2003-07-22 |
2006-08-17 |
Cytos Biotechnology Ag |
Cpg-packaged liposomes
|
EP2481422A3
(en)
|
2003-09-03 |
2013-04-03 |
Dendritherapeutics, Inc. |
Multiplex vaccines
|
CN1609617B
(zh)
*
|
2003-09-29 |
2012-02-15 |
香港中文大学 |
诊断与预防严重急性呼吸道综合症(sars)的组合物和方法
|
SG166117A1
(en)
|
2003-12-10 |
2010-11-29 |
Canji Inc |
Methods and compositions for treatment of interferon-resistant tumors
|
CN1559607A
(zh)
|
2004-02-20 |
2005-01-05 |
�й�ũҵ��ѧ |
一种核酸物质与蛋白质类组合物及其生产方法和在免疫调节中的应用
|
JP5393978B2
(ja)
|
2004-04-05 |
2014-01-22 |
ゾエティス・ピー・エルエルシー |
マイクロ流動化された水中油型乳剤及びワクチン組成物
|
GB0716992D0
(en)
|
2007-08-31 |
2007-10-10 |
Immune Targeting Systems Its L |
Influenza antigen delivery vectors and constructs
|
US7303881B2
(en)
|
2004-04-30 |
2007-12-04 |
Pds Biotechnology Corporation |
Antigen delivery compositions and methods of use
|
US7745651B2
(en)
|
2004-06-07 |
2010-06-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use
|
CA2572389A1
(en)
*
|
2004-06-30 |
2006-06-29 |
Id Biomedical Corporation Of Quebec |
Vaccine compositions for treating coronavirus infection
|
WO2006007712A1
(en)
|
2004-07-19 |
2006-01-26 |
Protiva Biotherapeutics, Inc. |
Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents
|
DE102004057303A1
(de)
*
|
2004-11-26 |
2006-06-01 |
Merck Patent Gmbh |
Stabile Kristallmodifikationen von DOTAP Chlorid
|
US8106092B2
(en)
|
2004-12-13 |
2012-01-31 |
Leo Laboratories Limited |
Treatment of solid cancers
|
WO2006065960A2
(en)
*
|
2004-12-14 |
2006-06-22 |
Applera Corporation |
Cationic liposomes comprising a charge neutral compound and a cationic phospholipid
|
AU2006206267A1
(en)
|
2005-01-21 |
2006-07-27 |
Introgen Therapeutics, Inc. |
Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
|
RU2007138027A
(ru)
|
2005-03-14 |
2009-04-20 |
Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем (Us) |
Биоактивные пептиды fus-1 и комплексы полипептидов с наночастицами
|
EP1864549A1
(en)
|
2005-03-18 |
2007-12-12 |
Widex A/S |
Remote control system for a hearing aid
|
JP5020935B2
(ja)
|
2005-04-08 |
2012-09-05 |
アルゴス セラピューティクス,インコーポレイティド |
樹状細胞組成物および方法
|
WO2006113214A2
(en)
|
2005-04-11 |
2006-10-26 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Vaccine against pandemic strains of influenza viruses
|
US20060275777A1
(en)
|
2005-06-03 |
2006-12-07 |
Waelti Ernst R |
Novel strategies for protein vaccines
|
US20070059318A1
(en)
|
2005-08-15 |
2007-03-15 |
Balu-Iyer Sathy V |
Lipid nano particulates containing antigens as cancer vaccines
|
US20110305713A1
(en)
|
2005-10-21 |
2011-12-15 |
Medical College Of Georgia Research Institute, Inc |
Methods and compositions to enhance vaccine efficacy by reprogramming regulatory t cells
|
US7527801B2
(en)
|
2005-11-22 |
2009-05-05 |
Novartis Vaccines And Diagnostics, Inc. |
Norovirus and Sapovirus antigens
|
US8802419B2
(en)
*
|
2006-03-02 |
2014-08-12 |
University Of Massachusetts |
Modified pathogens for use as vaccines
|
JP2007238559A
(ja)
|
2006-03-10 |
2007-09-20 |
Nagoya City Univ |
未成熟樹状細胞活性化剤及びその使用
|
AU2007241406A1
(en)
|
2006-04-21 |
2007-11-01 |
Transgene S.A. |
HPV-16-based papillomavirus vaccine
|
US20080014251A1
(en)
|
2006-07-14 |
2008-01-17 |
Advanced Vascular Dynamics |
Hemostatic compound and its use
|
EP1894941A1
(en)
|
2006-09-01 |
2008-03-05 |
Institut Pasteur |
Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens
|
WO2008039874A2
(en)
|
2006-09-26 |
2008-04-03 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
EP2073818A4
(en)
|
2006-10-18 |
2010-09-15 |
Us Gov Health & Human Serv |
IMPROVEMENT OF ILLNESS RESISTANCE TO RNA VIRUS INFECTIONS WITH INTRA-CYCLOPIC ENSURE SENSORS
|
KR100817024B1
(ko)
|
2006-11-09 |
2008-03-26 |
재단법인 목암생명공학연구소 |
핵산 또는 약물을 간에 특이적으로 전달하는 복합체 및이를 포함하는 약학적 조성물
|
US8877206B2
(en)
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
WO2008148057A2
(en)
|
2007-05-23 |
2008-12-04 |
Vical Incorporated |
Cationic lipids compositions and methods for enhancing immune responses to vaccines
|
US7832751B2
(en)
*
|
2007-06-29 |
2010-11-16 |
Harley-Davidson Motor Company Group, Inc. |
Rear fender assembly
|
BRPI0818154A2
(pt)
|
2007-11-02 |
2020-10-06 |
The Johns Hopkins University |
composições de peptídeo de hpv de multitipo e métodos para o tratamento ou prevenção de infecção por papilomavírus humano
|
CN110075113A
(zh)
|
2008-04-17 |
2019-08-02 |
Pds生物科技公司 |
通过阳离子脂质的对映体刺激免疫应答
|
WO2009142893A2
(en)
|
2008-05-19 |
2009-11-26 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for the delivery of bioactive compounds
|
US20100086584A1
(en)
|
2008-09-18 |
2010-04-08 |
Juvaris Biotherapeutics, Inc. |
VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
|
CA2754826A1
(en)
|
2009-03-06 |
2010-09-10 |
Mount Sinai School Of Medicine |
Live attenuated influenza virus vaccines comprising microrna response elements
|
CA3017298C
(en)
|
2009-05-15 |
2021-09-28 |
Irx Therapeutics, Inc. |
Compositions comprising primary cell-derived biologics for enhancing immune responses in patients
|
WO2011109294A1
(en)
|
2010-03-01 |
2011-09-09 |
Dicerna Pharmaceuticals, Inc. |
Lipid delivery formulations
|
EP3248615A1
(en)
|
2010-03-30 |
2017-11-29 |
Mount Sinai School of Medicine of New York University |
Influenza virus vaccines and uses thereof
|
KR101773643B1
(ko)
|
2010-04-28 |
2017-08-31 |
교와 핫꼬 기린 가부시키가이샤 |
양이온성 지질
|
KR20140054140A
(ko)
|
2011-07-27 |
2014-05-08 |
베일러 리서치 인스티튜트 |
췌장암에 대한 수지상 세포(dc) - 백신 치료요법
|
WO2013039989A1
(en)
|
2011-09-12 |
2013-03-21 |
Pds Biotechnology Corporation |
Particluate vaccine formulations
|
EP2638896A1
(en)
|
2012-03-14 |
2013-09-18 |
Bioneer A/S |
Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
KR20150058139A
(ko)
|
2012-06-15 |
2015-05-28 |
피디에스 바이오테크놀러지 코퍼레이션 |
양이온성 지질 백신 조성물 및 이용 방법
|
JP2015530413A
(ja)
|
2012-09-21 |
2015-10-15 |
ベデュ−アッド,フランク |
改良されたワクチン組成物および使用方法
|
PE20160224A1
(es)
|
2013-08-21 |
2016-05-14 |
Curevac Ag |
Composicion y vacuna para tratar cancer de pulmon
|
US10035832B2
(en)
|
2013-10-23 |
2018-07-31 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
|
CN104189897A
(zh)
|
2014-05-21 |
2014-12-10 |
深圳先进技术研究院 |
一种树突状细胞高效负载抗原的制备方法
|
AU2016232280B2
(en)
|
2015-03-16 |
2018-05-31 |
Helmholtz Zentrum München-Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) |
Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell library
|
CN105920599B
(zh)
|
2015-09-17 |
2020-02-11 |
武汉生物制品研究所有限责任公司 |
以阳离子脂质体dotap为佐剂的疫苗及其制备方法
|
EP4092112A1
(en)
|
2015-11-13 |
2022-11-23 |
PDS Biotechnology Corporation |
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
|
AU2017340407A1
(en)
|
2016-10-05 |
2019-05-02 |
Pds Biotechnology Corporation |
Novel HPV16 non HLA-restricted T-cell vaccines, compositions and methods of use thereof
|
US20180221475A1
(en)
|
2016-10-05 |
2018-08-09 |
Pds Biotechnology Corporation |
Methods to alter the tumor microenvironment for effective cancer immunotherapy
|
CN111655238A
(zh)
|
2017-12-05 |
2020-09-11 |
Pds生物科技公司 |
用于刺激i型干扰素基因的包括阳离子脂质的方法和组合物
|
CN111217918B
(zh)
*
|
2020-03-04 |
2020-11-10 |
中山大学 |
一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗
|